Pulmonary artery compliance in different forms of pulmonary hypertension

• Published in: Heart (British Cardiac Society) Vol. 109; no. 14; p. 1098
• Main Authors: McCormick, Amber, Krishnan, Amita, Badesch, David, Benza, Raymond L, Bull, Todd M, De Marco, Teresa, Feldman, Jeremy, Hemnes, Anna R, Hirsch, Russel, Horn, Evelyn, Kennedy, Jaime, Mathai, Stephen C, McConnell, Wesley, Pugliese, Steven C, Sager, Jeffrey S, Shlobin, Oksana A, Simon, Marc A, Lammi, Matthew R
• Format: Journal Article
• Language: English
• Published: England 01-07-2023
• Subjects: Adult; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Pulmonary Arterial Hypertension; Pulmonary Artery - surgery; Retrospective Studies; Pulmonary Embolism; Pulmonary Arterial Hypertension
• ISSN: 1468-201X
• DOI: 10.1136/heartjnl-2022-321760

Pulmonary artery compliance (PAC), estimated as stroke volume (SV) divided by pulmonary artery pulse pressure (PP), may be a predictor of survival in pulmonary arterial hypertension (PAH). Resistance-compliance (RC) time, the product of PAC and pulmonary vascular resistance, is reported to be a physiological constant. We investigated if differences in PAC and RC time exist between pulmonary hypertension (PH) subgroups and examined whether PAC is an independent predictor of transplant-free survival in PAH.
This was a retrospective analysis of adult PAH (n=532) and chronic thromboembolic PH (CTEPH, n=84) patients enrolled in the US Pulmonary Hypertension Association Registry from 2015 to 2019. PAC and RC time were compared between PH subgroups (connective tissue disease-PAH (CTD-PAH), idiopathic/heritable-PAH (i/h-PAH), drug/toxin-PAH (d/t-PAH)). Cox proportional hazards models were constructed for transplant-free survival, adjusting for REVEAL 2.0 risk score.
There were no differences in estimated PAC between PAH subgroups, nor between PAH and CTEPH. RC time was shorter in CTEPH compared with PAH (median 0.55 (IQR 0.45-0.64) vs 0.62 (0.52-0.73) s, p<0.0001). RC time was shortest in CTD-PAH when compared with i/h-PAH and d/t-PAH ((0.59±0.18) vs (0.65±0.20) vs (0.73±0.25) s, p=0.0001). PAC was associated with transplant-free survival (HR 0.72, 95% CI 0.55 to 0.94, p=0.02) but was not an independent predictor of outcome after adjustment for REVEAL 2.0 score.
PAC was similar between PH groups and was not an independent predictor of transplant-free survival in PAH. RC time was different between PH subgroups, challenging RC time constancy.
NCT04071327.